What is Ixazomib: Uses, Dosage, Side Effects and More

Ixazomib is a targeted cancer medication that works by blocking proteins that help cancer cells grow and survive. This oral medication belongs to a class of drugs called proteasome inhibitors, which essentially interfere with the cellular machinery that allows multiple myeloma cells to multiply.

You might be wondering about this medication if your doctor has recommended it as part of your cancer treatment plan. Understanding how ixazomib works and what to expect can help you feel more confident about your treatment journey.

What is Ixazomib?

Ixazomib is an oral chemotherapy drug specifically designed to treat multiple myeloma, a type of blood cancer that affects plasma cells in your bone marrow. The medication comes in capsule form, making it more convenient than many other cancer treatments that require hospital visits.

This drug is what doctors call a "second-generation" proteasome inhibitor. Think of proteasomes as tiny recycling centers inside cells that break down old or damaged proteins. Cancer cells rely heavily on these recycling centers to survive and grow rapidly.

By blocking these proteasomes, ixazomib essentially overwhelms cancer cells with protein waste they cannot process. This causes the cancer cells to die while having less impact on healthy cells that don't depend as heavily on this protein recycling system.

What is Ixazomib Used For?

Ixazomib is primarily used to treat multiple myeloma in adults who have already received at least one other treatment. Your doctor will typically prescribe it alongside two other medications called lenalidomide and dexamethasone as part of a combination therapy approach.

Multiple myeloma is a cancer that starts in plasma cells, which are a type of white blood cell found in your bone marrow. These cells normally help your immune system fight infections by producing antibodies. When they become cancerous, they multiply uncontrollably and crowd out healthy blood cells.

This medication is specifically approved for patients whose cancer has returned after previous treatments or has not responded well to other therapies. It represents an important option for people who need ongoing treatment to manage their condition.

How Does Ixazomib Work?

Ixazomib works by targeting a specific weakness in cancer cells. It blocks proteasomes, which are like cellular garbage disposals that break down old proteins. Cancer cells produce proteins much faster than normal cells, so they rely heavily on these proteasomes to clear out the excess.

When ixazomib blocks these proteasomes, cancer cells become overwhelmed with protein buildup and essentially suffocate from their own waste products. This process is called apoptosis, or programmed cell death, and it happens naturally when cells become too damaged to function properly.

The medication is considered moderately strong compared to other cancer treatments. It can cause significant side effects, but many people find it more manageable than traditional intravenous chemotherapy because you can take it at home as a pill.

How Should I Take Ixazomib?

Take ixazomib exactly as your doctor prescribes, typically once weekly on the same day each week. The standard dose is usually 4 mg, but your doctor may adjust this based on how well you tolerate the medication and how your cancer responds.

You should take this medication on an empty stomach, at least one hour before eating or at least two hours after eating. Swallow the capsule whole with a full glass of water - don't open, crush, or chew it. If you vomit within an hour of taking your dose, don't take another capsule that day.

Try to take your dose at the same time each week to maintain consistent levels in your body. Many people find it helpful to set a weekly reminder on their phone or calendar. Store the capsules in their original container at room temperature, away from moisture and heat.

How Long Should I Take Ixazomib For?

Most people take ixazomib for as long as it continues to work effectively against their cancer and the side effects remain manageable. Treatment cycles typically last 28 days, with you taking the medication on days 1, 8, and 15 of each cycle, then having a week off.

Your doctor will monitor your response through regular blood tests and imaging studies. Some people may take this medication for several months, while others might continue for a year or longer. The duration depends on how well your cancer responds and how your body tolerates the treatment.

Your healthcare team will regularly assess whether the benefits of continuing treatment outweigh any side effects you're experiencing. They may adjust your dose or recommend treatment breaks if needed to help manage any complications.

What Are the Side Effects of Ixazomib?

Like all cancer medications, ixazomib can cause side effects, though not everyone experiences them. Most side effects are manageable with proper monitoring and supportive care from your healthcare team.

Here are the most common side effects you might experience:

• Digestive issues: Diarrhea, nausea, vomiting, and constipation are quite common. These usually improve as your body adjusts to the medication.
• Skin problems: Rash, itching, and dry skin affect many people. Your doctor can recommend moisturizers and medications to help manage these symptoms.
• Fatigue: Feeling tired or weak is very common. This may be related to both the medication and the cancer itself.
• Nerve problems: Numbness, tingling, or pain in your hands and feet (peripheral neuropathy) can occur but is often less severe than with other similar medications.
• Back pain: This is a frequently reported side effect that can usually be managed with pain medications.

Some people may experience more serious but less common side effects. These require immediate medical attention and include severe infections, unusual bleeding or bruising, difficulty breathing, or signs of liver problems like yellowing of the skin or eyes.

Your healthcare team will monitor you closely for these effects through regular blood tests and check-ups. Don't hesitate to contact them if you notice any concerning symptoms, even if they seem minor.

Who Should Not Take Ixazomib?

Ixazomib isn't suitable for everyone. Your doctor will carefully evaluate whether this medication is safe for you based on your overall health, other medications you're taking, and your specific medical history.

You should not take ixazomib if you're allergic to it or any of its ingredients. Women who are pregnant or breastfeeding should not use this medication, as it can harm a developing baby. If you're of childbearing age, you'll need to use effective contraception during treatment and for several months afterward.

People with severe liver problems may not be able to take this medication safely. Your doctor will check your liver function before starting treatment and monitor it regularly throughout your therapy.

If you have a history of heart problems, blood clots, or severe infections, your doctor will need to weigh the benefits and risks carefully. They may recommend additional monitoring or choose a different treatment approach.

Ixazomib Brand Names

Ixazomib is sold under the brand name Ninlaro in most countries, including the United States. This is currently the only brand name available for this medication, as it's still under patent protection.

You might also hear healthcare providers refer to it by its chemical name, ixazomib citrate, particularly in medical literature or research studies. However, when you pick up your prescription, you'll see it labeled as Ninlaro.

The medication is manufactured by Takeda Pharmaceuticals and is available only through specialty pharmacies that have experience handling cancer medications. Your healthcare team will help arrange for you to receive your medication through one of these specialized facilities.

Ixazomib Alternatives

If ixazomib isn't suitable for you or stops working effectively, several other treatment options are available for multiple myeloma. Your doctor might consider other proteasome inhibitors like bortezomib (Velcade) or carfilzomib (Kyprolis), though these are typically given as injections rather than pills.

Immunomodulatory drugs like lenalidomide (Revlimid) or pomalidomide (Pomalyst) work differently by enhancing your immune system's ability to fight cancer cells. Newer treatments include monoclonal antibodies such as daratumumab (Darzalex) or elotuzumab (Empliciti).

CAR-T cell therapy and other immunotherapy approaches are also becoming available for people with multiple myeloma. Your oncologist will consider factors like your previous treatments, overall health, and personal preferences when recommending the best alternative for your situation.

Is Ixazomib Better Than Bortezomib?

Both ixazomib and bortezomib are proteasome inhibitors that work similarly, but they have some important differences. The main advantage of ixazomib is that you can take it as a pill at home, while bortezomib requires injections at a medical facility.

Studies suggest that ixazomib may cause less severe nerve damage (peripheral neuropathy) compared to bortezomib, which is a significant concern for many patients. However, bortezomib has been used longer and has more extensive research supporting its effectiveness.

The choice between these medications depends on various factors including your treatment history, lifestyle preferences, and how well you tolerate side effects. Your doctor will help you weigh the pros and cons of each option based on your specific situation and treatment goals.